$3.22
-0.40-11.05%
Last update: Nov 5, 7:53 PM
Wave Life Sciences Inc
WVENASDAQ
The average analyst price target for Wave Life Sciences is $22.12, 574.4% above the current price. Of 21 analysts, 20 rate it Buy and 1 Hold. Targets range from $10 to $50. The latest change came on Oct 29, 2026, when Canaccord Genuity raised its price target on Wave Life Sciences from $42 to $44 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 21 Analysts
Rating Trend — Last 9 Months
